Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000939767-25-000045
Filing Date
2025-02-28
Accepted
2025-02-28 20:35:48
Documents
1
Period of Report
2025-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1740792942.html 4  
1 FORM 4 wk-form4_1740792942.xml 4 15916
  Complete submission text file 0000939767-25-000045.txt   17557
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Issuer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0103
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O RAPTOR PHARMACEUTICAL CORP 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949
Business Address
Smith Julie (Reporting) CIK: 0001557928 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30235 | Film No.: 25693265